key: cord-0025062-nssr3yv0
authors: Mungmunpuntipantip, Rujittika; Wiwanitkit, Viroj
title: Re: “Transient Eyelid Edema Following COVID-19 Vaccination”
date: 2022-01-04
journal: Ophthalmic Plast Reconstr Surg
DOI: 10.1097/iop.0000000000002098
sha: 753d3d96a437f4ba21a801ff69c6ac567952e559
doc_id: 25062
cord_uid: nssr3yv0

nan

A Case Report." 1 They note that in the aforementioned article, I suggest a temporal relationship between the patient's coronavirus disease 2019 (COVID-19) vaccine and thyroid eye disease (TED) due to an inflammatory syndrome. I agree that this one case does not in and of itself clinch the exact pathogenesis of this relationship, and indeed it may be coincidental, as I mention in the article.

Among other possibilities that Drs. Sriwijitalai and Wiwanitkit suggest, I believe an inflammatory pathogenesis is the best explanation. First, the patient's thyroid hormone panel was normal, so thyroid hormone abnormality triggering TED is less likely. Second, as indicated in the article, she presented with elevated thyroid stimulating immunoglobulin (TSI), an antibody with high specificity to TED and with a relationship with more severe orbitopathy. 2 However, it is unknown what the TSI was before the vaccination, as TSI may still be elevated in chronic TED. 3 Third, the patient's response to teprotumumab-an insulin-like growth factor 1 receptor blocking antibody-indicates an inflammatory role rather than a hyperviscosity role. The patient had no other signs and symptoms of hyperviscosity systemically, nor such findings on orbital imaging or ophthalmic examination. I do agree, though, that further studies and cases are necessary to elucidate the pathogenesis further.

Transient eyelid edema following COVID-19 vaccination

Expected viscosity after COVID-19 vaccination, hyperviscosity and previous COVID-19

Right orbital edema masquerading a hematologic malignancy

Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves' disease: a case report

Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy

Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves' orbitopathy

To the Editor : We would like to share ideas on "Transient Eyelid Edema Following COVID-19 Vaccination." 1 Post-COVID-19 vaccination, ocular problem is an interesting clinical issue. Austria et al 1 discussed on possible immunopathological mechanism causing eyelid edema. However, there is no evidence of any abnormal immune laboratory parameters in this patient. In addition to immunity problem, the abnormality might also be explained by other pathobiological process. After COVID-19 vaccination, there might be a hyperviscosity problem. 2 Ocular edema is a rare but possible clinical presentation of a patient with hyperviscosity, such as a case with underlying myeloma. 3 The vaccine-induced hyperviscosity is due to rapid surge on immunoglobulin after vaccine administration, and the viscosity will decrease when time passes. 2 This might be an explanation for occurrence of transient ocular problem.